Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

Distinctive roles of syntaxin binding protein 4 and its action target, TP63, in lung squamous cell carcinoma: a theranostic study for the precision medicine

Abstract Background Lung squamous cell carcinoma (LSCC) remains a challenging disease to treat, and further improvements in prognosis are dependent upon the identification of LSCC-specific therapeutic biomarkers and/or targets. We previously found that Syntaxin Binding Protein 4 (STXBP4) plays a cru...

Full description

Bibliographic Details
Main Authors: Erkhem-Ochir Bilguun, Kyoichi Kaira, Reika Kawabata-Iwakawa, Susumu Rokudai, Kimihiro Shimizu, Takehiko Yokobori, Tetsunari Oyama, Ken Shirabe, Masahiko Nishiyama
Format: Article
Language:English
Published: BMC 2020-09-01
Series:BMC Cancer
Subjects:
STXBP4
Lung squamous cell carcinoma
Drug therapy
Molecular target
Biomarker
Online Access:http://link.springer.com/article/10.1186/s12885-020-07448-2

Internet

http://link.springer.com/article/10.1186/s12885-020-07448-2

Similar Items